Cargando…

Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and Beyond

The blood–brain barrier permeant, copper-containing compound, Cu(II)(atsm), has successfully progressed from fundamental research outcomes in the laboratory through to phase 2/3 clinical assessment in patients with the highly aggressive and fatal neurodegenerative condition of amyotrophic lateral sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nikseresht, Sara, Hilton, James B.W., Kysenius, Kai, Liddell, Jeffrey R., Crouch, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694234/ https://www.ncbi.nlm.nih.gov/pubmed/33158182 http://dx.doi.org/10.3390/life10110271

Ejemplares similares

Cu(II)(atsm) Attenuates Neuroinflammation
por: Choo, Xin Yi, et al.
Publicado: (2018)

Cu(II)(atsm) improves the neurological phenotype and survival of SOD1(G93A) mice and selectively increases enzymatically active SOD1 in the spinal cord
por: Hilton, James B., et al.
Publicado: (2017)

CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits
por: Vieira, Fernando G., et al.
Publicado: (2017)

CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1(G93A) mice with a C57BL/6 background
por: Lum, Jeremy S., et al.
Publicado: (2021)

Does the ATSM-Cu(II) Biomarker Integrate into the Human Cellular Copper Cycle?
por: Walke, Gulshan R., et al.
Publicado: (2019)

Metal-deficient SOD1 in amyotrophic lateral sclerosis
por: Hilton, James B., et al.
Publicado: (2015)

First Principles Calculation of Protein–Protein Dimer Affinities of ALS-Associated SOD1 Mutants
por: Hsueh, Shawn C. C., et al.
Publicado: (2022)

A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity
por: Joyce, Peter I., et al.
Publicado: (2015)

An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1
por: Prudencio, Mercedes, et al.
Publicado: (2010)

(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry
por: Hansen, Anders E, et al.
Publicado: (2012)

A Copper Binding Site within the Pathological Conformer Epitope of Mutant SOD1
por: Bush, Ashley I.
Publicado: (2011)

Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
por: Tang, Lu, et al.
Publicado: (2019)

Preclinical Pharmacokinetic and Safety Studies of Copper-Diacetyl-Bis(N(4)-Methylthiosemicarbazone) (Cu-ATSM): Translational Studies for Internal Radiotherapy
por: Matsumoto, Hiroki, et al.
Publicado: (2019)

SUMO3 Modification Accelerates the Aggregation of ALS-Linked SOD1 Mutants
por: Niikura, Takako, et al.
Publicado: (2014)

Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
por: Palomo, Gloria M, et al.
Publicado: (2018)

Structural Properties and Interaction Partners of Familial ALS-Associated SOD1 Mutants
por: Huai, Jisen, et al.
Publicado: (2019)

Correction to: Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
por: Tang, Lu, et al.
Publicado: (2019)

Copper Sources for Sod1 Activation
por: Boyd, Stefanie D., et al.
Publicado: (2020)

Regular Physical Exercise Modulates Iron Homeostasis in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Belaya, Irina, et al.
Publicado: (2021)

Cellular Uptake of the ATSM−Cu(II) Complex under Hypoxic Conditions
por: Walke, Gulshan R., et al.
Publicado: (2021)

Mutant SOD1 Increases APP Expression and Phosphorylation in Cellular and Animal Models of ALS
por: Rabinovich-Toidman, Polina, et al.
Publicado: (2015)

Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS
por: Vieira, Fernando G., et al.
Publicado: (2015)

Pro-Oxidant Activity of an ALS-Linked SOD1 Mutant in Zn-Deficient Form
por: Nagao, Chise, et al.
Publicado: (2020)

Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1
por: Brasil, Aline de Araújo, et al.
Publicado: (2019)

Increased surface P2X4 receptors by mutant SOD1 proteins contribute to ALS pathogenesis in SOD1-G93A mice
por: Bertin, Eléonore, et al.
Publicado: (2022)

SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS
por: Gill, Cindy, et al.
Publicado: (2019)

Mitochondria-Targeted Catalase Reverts the Neurotoxicity of hSOD1(G93A) Astrocytes without Extending the Survival of ALS-Linked Mutant hSOD1 Mice
por: Pehar, Mariana, et al.
Publicado: (2014)

Modulation of SOD1 Subcellular Localization by Transfection with Wild- or Mutant-type SOD1 in Primary Neuron and Astrocyte Cultures from ALS Mice
por: Lee, Do-Yeon, et al.
Publicado: (2015)

ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2
por: Pedrini, Steve, et al.
Publicado: (2010)

Early Interneuron Dysfunction in ALS: Insights from a Mutant sod1 Zebrafish Model
por: McGown, Alexander, et al.
Publicado: (2013)

Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions
por: Farrawell, Natalie E., et al.
Publicado: (2015)

A molecular chaperone activity of CCS restores the maturation of SOD1 fALS mutants
por: Luchinat, Enrico, et al.
Publicado: (2017)

ALS-Linked SOD1 Mutants Enhance Neurite Outgrowth and Branching in Adult Motor Neurons
por: Osking, Zachary, et al.
Publicado: (2018)

ALS-Linked SOD1 Mutants Enhance Neurite Outgrowth and Branching in Adult Motor Neurons
por: Osking, Zachary, et al.
Publicado: (2019)

ALS-Related Mutant SOD1 Aggregates Interfere with Mitophagy by Sequestering the Autophagy Receptor Optineurin
por: Tak, Yeong Jin, et al.
Publicado: (2020)

Strategies to promote the maturation of ALS-associated SOD1 mutants: small molecules return to the fold
por: McAlary, Luke, et al.
Publicado: (2019)

Impaired ATF3 signaling involves SNAP25 in SOD1 mutant ALS patients
por: Yazar, Volkan, et al.
Publicado: (2023)

ALS-associated mutant SOD1(G93A )causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes
por: Higgins, Cynthia MJ, et al.
Publicado: (2003)

A VDAC1-Derived N-Terminal Peptide Inhibits Mutant SOD1-VDAC1 Interactions and Toxicity in the SOD1 Model of ALS
por: Shteinfer-Kuzmine, Anna, et al.
Publicado: (2019)

CuATSM effectively ameliorates ALS patient astrocyte‐mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis
por: Dennys, Cassandra N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oc5jbq9b1nlaeks9gj28c3ikqn